Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

May 31, 2002

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

filgrastim

as prescribed by physician

PROCEDURE

peripheral blood stem cell transplantation

1-2 weeks from treatment

RADIATION

indium In 111 monoclonal antibody MN-14

intravenous infusion over 30 min; single dose

RADIATION

yttrium Y 90 monoclonal antibody MN-14

intravenous infusion over 30 min; single dose

Trial Locations (3)

19104

University of Pennsylvania Cancer Center, Philadelphia

07103

Garden State Cancer Center, Belleville

07503

St. Joseph's Hospital and Medical Center, Paterson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

OTHER

NCT00004177 - Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter